BrokerLens

Nephro Care India Limited IPO (NEPHROCARE)

Status
Listed
Security type
SME
Price band
Rs.85 to Rs.90
Final issue price
Rs 90
Issue size
Not disclosed
Bidding opens
28 June 2024
Bidding closes
2 July 2024
Listing date
5 July 2024

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Nephro Care India Limited IPO?

The Nephro Care India Limited IPO price band is Rs.85 to Rs.90 per share.

When does the Nephro Care India Limited IPO open and close?

Bidding opens 28 June 2024 and closes 2 July 2024.

Is the Nephro Care India Limited IPO a mainboard or SME issue?

Nephro Care India Limited is an SME IPO, listing on NSE Emerge.

When did the Nephro Care India Limited IPO list?

Nephro Care India Limited listed on 5 July 2024.

Does this page show the grey market premium (GMP) for Nephro Care India Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Nephro Care India Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.